Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated.

Medically reviewed by Christopher Lee, MD Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that causes high blood pressure in the small arteries of the lungs. It is a serious ...

Learn 5 grim risks of ignoring chest pain early, from heart attacks to lung issues, and why quick action saves lives.

Pulmonary arteries are a type of blood vessel that is responsible for oxygen-rich blood from the heart to the lungs. It impacts the right side of the heart and arteries in the lungs. There can be ...

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and ...

Elastases were extracted from lung tissue as described ... killing without knowledge of the treatment group. Direct pulmonary artery catheterization was done and pressures were measured (ES ...

Discover why difficult breathing might indicate heart disease, lung conditions, anxiety disorders, or blood problems, and ...

Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and pulmonary hypertension were found.